Back to Search Start Over

Plasma HIV load and proviral DNA decreases after two standard antiretroviral regimens in HIV-positive patients naïve to antiretrovirals

Authors :
Giuseppe Lapadula
Michele Nichelatti
Andrea Cossarizza
Maria Eugenia Quiros-Roldan
Milena Nasi
Nino Manca
Giuliana Cologni
Silvia Costarelli
Franco Gargiulo
Carlo Torti
Francesca Ceresoli
Giampiero Carosi
Michele Magoni
Marcello Pinti
Torti, C
Quiros-Roldan, M
Cologni, G
Nichelatti, M
Ceresoli, F
Pinti, M
Nasi, M
Cossarizza, A
Lapadula, G
Costarelli, S
Manca, N
Gargiulo, F
Magoni, M
Carosi, G
Publication Year :
2008
Publisher :
BENTHAM SCIENCE PUBL LTD, 2008.

Abstract

(i) To compare early decrease of HIV plasma viral load (pVL) after two standard-combinations of highly active antiretroviral therapy (HAART) (ii) To evaluate variations of proviral HIV-DNA load on conditions of sustained pVL undetectability. Two different sub-studies of a multicentre prospective randomized controlled trial which compared two first-line HAART (i.e., zidovudine+lamivudine+lopinavir/ritonavir versus tenofovir+lamivudine+ efavirenz). Only patients enrolled at the coordinating centre (University of Brescia) were included in the two sub-studies. In the first sub-study, we calculated pVL decrease with respect to baseline at any of the following time-point: days 1, 3, 7, 14 and 28. Decreases of the pVL were compared between the two treatment groups. In the second sub-study, we'analyzed, variation of proviral HIV-DNA load in CD4+ T-cells from baseline to week 52 only in patients who maintained the same treatment regimen and had sustained undetectable pVL. In either studies, linear regression analysis was used to investigate what factors could influence variations of pVL and of proviral HIV-DNA load. (i) 64 patients were studied. A significant decrease of pVL was found from day 3 on, without statistically significant differences between the two study groups. However, after adjusting for possible confounders, tenofovir+lamivudine+efavirenz resulted to be associated with greater pVL decreases. (ii) 45 patients were studied. Mean proviral HIV-DNA load decreased from 1,610 (95%CI: 879-2,341) to 896 (95% CI 499-1,293) copies/106 cells (P=0.05). Linear regression analysis showed that the decrease of proviral DNA load during follow-up was independently and inversely correlated with age. Further studies are needed to compare pVL decay between antiretroviral regimens and assess whether proviral HIV-DNA load is a surrogate marker of treatment effectiveness. © 2008 Bentham Science Publishers Ltd.

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....f143f4fb5fd01fd590a3593cd4a0f704